[Changes in serum AspAT and AlAT in patients with chronic peripheral arterial obliteration treated with streptokinase].
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood*; D001157:Arterial Occlusive Diseases / Q000188:drug therapy* / Q000201:enzymology; D001219:Aspartate Aminotransferases / Q000097:blood*; D006801:Humans; D008099:Liver / Q000201:enzymology; D008875:Middle Aged; D013300:Streptokinase / Q000627:therapeutic use*
D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D013300:Streptokinase
Zmiany aktywności aminotransferaz AlAT i AspAT w surowicy krwi u chorych z przewlekła niedroznościa tetnic obwodowych leczonych streptokinaza